North America currently leads the DNA Synthesis Market due to its mature biotech ecosystem, heavy investment in genomics, and ...

According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...

There’s an old saying about a dollar waiting on a dime. In other words, a monumental endeavor may become stuck at some point if a key preliminary element remains unavailable. The saying could be ...

The synthetic DNA maker Twist Bioscience announced at the J.P. Morgan Health Care Conference earlier this month that it is developing enzymatic DNA synthesis technology. The revelation—by a major ...

DNA enzymatic synthesis represents an enormously valuable next step in harnessing the power of DNA replication and our ability to use it for developing cutting-edge, biotechnology solutions. DNA (or ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Gene synthesis is a ...

The state of DNA synthesis is a bit like humanity’s journey to the moon—just because something has been achieved before doesn’t mean we should cease figuring out how to do it better.” That is how ...

DNA is the raw material of modern medicine yet is the only part of drug development not accessible at the lab bench. DNA synthesis, the first step in most biological workflows including gene synthesis ...